Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Pulmonx Corporation (NASDAQ: LUNG)
LUNG Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
11.80%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
252.70%
LUNG Stock Analysis
LUNG
PE Ratio:
LUNG
PEG Ratio:
Not Available
LUNG
Forward EPS Growth (12 month):
0.00%
LUNG
PS Ratio:
0.7
LUNG
PSG Ratio:
LUNG
Forward Revenue Growth (12 month):
17.50%
LUNG Articles
No data was found